Multiple cardiovascular outcome trials (ELIXAlixisenatide, LEADERliraglutide, SUSTAIN-6semaglutide, EXSCELexenatide, Harmony Outcomesalbiglutide, REWINDdulaglutide, and PIONEER-6oral semaglutide) have reported, to a greater or lesser extent, improvements in cardiovascular outcomes, with a systematic review and meta-analysis of these trials involving a combined total of 56,004 participants showing that these drugs as a class reduced major adverse cardiovascular events by 12%, death from cardiovascular causes by 12%, fatal or nonfatal stroke by 16%, and fatal or nonfatal myocardial infarction by 9%
Suggested Use: Take 2 tablets daily, 1 in the morning and 1 at night
Add carrots and ginger
If you have left your patch on for an extended period of time, over 16 hours, then take the patch off and give your body a full day of rest before you re-patch the same patch
Samples for analysis were fractionated via Pierce High pH Reversed-Phase Peptide Fractionation kit (Thermo Fisher Scientific) according to Manufacturers instructions